Search
for
Sort by
Research 31–60 of 1000+
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era